zhoujing
Academic / Other · 1 registered clinical trial — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | Neoadjuvant Nab-Paclitaxel Plus Oxaliplatin, S-1, and Sintilimab in Early-Onset Resectable Gastric Cancer Gastric (Cardia, Body) Cancer, Stomach Adenocarcinoma, Locally Advanced | Phase 2 | 2025-10-01 |